David Moatazedi
See Remarks at Evolus Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2022
8 years of board service in total across 2 boards, counting each seat separately. Longest: Biomerica Inc., 3 years.
Biomerica Inc.
Director
Evolus Inc.
Director · See Remarks
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 23, 2024 | Evolus Inc. | Open-market sale | −10,502 | $10.85 | $113,947 |
| Dec 13, 2024 | Biomerica Inc. | Grant or award | +85,000 | $0.31 | $26,350 |
| Jun 6, 2024 | Evolus Inc. | Option exercise | +175,940 | $7.28 | $1,280,843 |
| Jun 6, 2024 | Evolus Inc. | Open-market sale | −175,940 | $12.59 | $2,215,085 |
| Jun 5, 2024 | Evolus Inc. | Option exercise | +155,278 | $5.46 | $847,818 |
| Jun 5, 2024 | Evolus Inc. | Open-market sale | −155,278 | $12.92 | $2,006,192 |
| Jun 4, 2024 | Evolus Inc. | Open-market sale | −140,214 | $12.73 | $1,784,924 |
| May 10, 2024 | Evolus Inc. | Open-market sale | −16,051 | $12.72 | $204,169 |
| Mar 27, 2024 | Evolus Inc. | Open-market sale | −6,236 | $13.86 | $86,431 |
| Mar 19, 2024 | Evolus Inc. | Open-market sale | −96,566 | $13.92 | $1,344,199 |
| Feb 22, 2024 | Evolus Inc. | Open-market sale | −7,706 | $13.08 | $100,794 |
| Feb 21, 2024 | Evolus Inc. | Grant or award | +61,202 | — | — |
| Feb 7, 2024 | Evolus Inc. | Grant or award | +134,976 | — | — |
| Dec 8, 2023 | Evolus Inc. | Open-market sale | −31,300 | $9.73 | $304,549 |
| Dec 6, 2023 | Evolus Inc. | Open-market sale | −51,348 | $10.09 | $518,101 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.